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Abstract
Background. Thermal ablative techniques have gained increasing popularity in recent years as safe and effective options for
patients with unresectable solid malignancies. Microwave ablation has emerged as a relatively new technique with the
promise of larger and faster burns without some of the limitations of radiofrequency ablation (RFA). Here we study a new
microwave ablation device in a living porcine model using gross, histologic, and radiographic analysis. Materials and methods.
The size and shape of ablated lesions were assessed using six pigs in a non-survival study. Liver tissue was ablated using 2, 4,
and 8 min burns, in both peripheral and central locations, with and without vascular inflow occlusion. To characterize the
post-ablation appearance, three additional pigs underwent several 4 min ablations each followed by serial computed
tomography (CT) imaging at 7, 14, and 28 days postoperatively. Results. The 2 and 4 min ablations resulted in lesions that
were similar in size, 33.5 cm3 and 37.5 cm3, respectively. Ablations lasting 8 min produced lesions that were significantly
larger, 92.0 cm3 on average. Proximity to hepatic vasculature and inflow occlusion did not significantly change lesion size or
shape. In follow-up studies, CT imaging showed a gradual reduction in lesion volume over 28 days to 2550% of the
original volume. Discussion. Microwave ablation with a novel device results in consistently sized and shaped lesions.
Importantly, we did not observe any significant heat-sink effect using this device, a major difference from RFA techniques.
This system offers a viable alternative for creating fast, large ablation volumes for treatment in liver cancer.
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Introduction
In recent years there has been a growing interest in
interstitial ablative approaches for the treatment of
unresectable tumors in the liver and other solid
organs. In addition to increasing the number of
patients eligible for potentially curative therapy, local
tissue ablation is often performed with lower morbid-
ity than resection. Moreover, it can be employed using
both percutaneous and laparoscopic minimally inva-
sive approaches as well as with open surgery.
A variety of methods have been used to locally
ablate tissue. Thermal ablation using radiofrequency
ablation (RFA) is currently the most frequently used
modality [13]. However, high local recurrence rates
have been reported in patients treated with RFA,
particularly for lesions 3.0 cm in diameter [39].
RFA is also potentially limited by the heat-sink effect
of nearby vessels resulting in incomplete tumor
ablation [1012]. The rate of heating during RFA
can be slow compared with other techniques. In
addition, the zone of active heating created by RFA
is typically small, often requiring multiple overlapping
zones to achieve a larger ablation lesion. As a result,
RFA procedure times can be prohibitively long.
Microwave ablation, an alternative method of
thermal ablation, offers many of the advantages of
RFA and has several other theoretical advantages that
may increase its effectiveness in tumor killing [13].
One limitation of traditional microwave ablation
therapy has been the inability to treat large tumors
without numerous overlapping ablations [14]. Recent
advances in the engineering of the microwave anten-
nas using ceramic probes have succeeded in improv-
ing the speed and size of the ablation [15]. The
Microsulis Tissue Ablation (MTA) system (Micro-
sulis Ltd, Edinburgh, UK) is a new microwave
ablation device with the potential for larger, faster,
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and potentially more accurate burns [15]. Most
studies of this device report on short-term perfor-
mance in ex vivo models. Therefore, we elected to
study this device in a more realistic clinically relevant
setting in an in vivo porcine model. A variety of
clinically relevant parameters were evaluated, includ-
ing the power, time, and ablation volume relationship;
effects of ablation location and inflow occlusion; and
short-term follow-up to characterize the post-ablation
appearance on serial CT imaging.
Materials and methods
Microwave ablation
The Microsulis Tissue Ablation (MTA) system
was used for all experiments. The MTA employs a
2.45 GHz, 100 W microwave device with an active
5.7 mm diameter radiator, powered by a magnetron
generator. A microwave detector was used to ensure
safe exposure of microwave energy to all personnel.
Animals
Swine weighing 4060 lb were used in the study. All
animals were treated in accordance with Johns Hop-
kins University Animal Care and Use Committee
protocols.
Non-survival studies
Animals underwent general anesthesia and an open
laparotomy was performed. The microwave ablation
applicator probe was inserted into the liver parench-
yma utilizing ultrasound guidance to optimize and
characterize position relative to major vascular struc-
tures. To determine the effect of ablation time on the
size and shape of lesions, ablations were performed
using 100 W of power for 2, 4, or 8 min durations.
These parameters were chosen on the basis of
established heating curve data in liver for the MTA
system [15].
One limitation of RFA techniques is the inability to
achieve consistently shaped burns when near vascu-
lature, known as the ‘heat-sink effect.’ To evaluate this
in our study, we compared the shape and size of
ablation lesions when the probe was placed periph-
erally in liver or centrally, in proximity to major
vasculature. Central ablations were conducted with
probe placement under ultrasound guidance within
1 cm of the origin of a major hepatic vein. To further
characterize the effect of adjacent blood flow, both
central and peripheral lesions were compared with
and without temporary total in-flow occlusion. This
was done with the application of a non-crushing
clamp on the porta hepatis during the ablation period.
Hemodynamic monitoring was performed through-
out each ablation, and the amount of bleeding upon
withdrawal of the applicator probe was also recorded.
Pigs were euthanized immediately following ablation
procedures.
Survival studies
The purpose of this series of experiments was to
determine the change in size and shape of ablated
lesions in living pigs over time and to correlate these
changes with radiologic and histopathologic data. In
three pigs, lesions were created in peripheral liver
parenchyma without inflow occlusion. In each animal,
two or three 100W 8 min ablations were performed.
These pigs were recovered from surgery and under-
went CT imaging at 7, 14, and 28 day intervals.
Following the last imaging, animals were euthanized,
livers were harvested, and ablated lesions were mea-
sured grossly as well as cross-sectioned and examined
microscopically using vital staining.
Liver evaluation
The livers were harvested en bloc and sliced at 3 mm
intervals. Lesion size was measured in the short
axis and long axis in relation to the applicator
probe. Lesion volume is calculated as 4/3p(short
axis/2)2(long axis/2). Portions of these liver samples
were then fixed in 10% formalin, mounted in paraffin
blocks, sliced at a thickness of 10 mm, and stained
with hematoxylin and eosin (H&E). Slices were
imaged on an optical scanner and saved as electronic
files.
Ablation volume and shape determination
Radiologic studies were conducted by a radiologist
(I.R.K.) blinded to the treatment group and time.
Image processing was performed using a commercially
available Advantage Windows workstation (General
Electric Medical Systems, Milwaukee, WI, USA).
Measurement of liver volume was performed by
hand tracing the tumor contour on the axial portal
venous phase images as described in prior studies
[16,17]. Hand tracing was performed on every axial
image to enhance accuracy in volumetric measure-
ments. A three-dimensional model of the liver and
tumor was generated.
Statistical analysis
The student’s t test was used for all analyses.
A pB0.05 level was used to determine statistical
significance.
Results
Safety and performance studies
The 100 W ablations of varying duration (2, 4, and
8 min) resulted in consistent and grossly evident
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ablations (Figure 1). Lesions were roughly ellipsoid in
shape, becoming more spherical with longer ablation
time. Table I summarizes the short-axis and long-axis
diameters as well as the total ablation volume.
Ablations lasting 2 min resulted in lesions that had
an average volume of 33.5 cm3 (short-axis diameter
3.7 cm). Ablations lasting 4 min were not statistically
larger, with an average volume of 37.5 cm3 and
average short-axis diameter of 3.8 cm. At 8 min,
ablation lesions were significantly larger, with the
short axis diameter averaging 5.3 cm and the average
volume averaging 92.0 cm3.
Histologic assessment of the areas of ablation
confirmed complete necrosis in the entire regions
seen and measured on gross examination. Moreover, a
sharp transition zone was identified between ablated
tissue and normal appearing liver parenchyma corre-
lating with the gross assessment (Figure 2).
There were no identifiable problems or complica-
tions during the liver ablation in the animals. They
remained hemodynamically stable throughout the
procedures and bleeding was not problematic either
during ablation or upon removal of the probes.
Impact of location and inflow occlusion on ablation
characteristics
The results of the ablation location and inflow
occlusion studies are shown in Table II. Applications
of 100 W lasting 4 min were used for all ablations
during this experiment. Lesions created in the per-
ipheral liver without inflow occlusion were, on
average, 3.8 cm4.9 cm and 37.5 cm3 in size. Appli-
cation of inflow occlusion in comparable peripheral
lesions resulted in increased size, averaging 4.4 cm
6.1 cm and 64.5 cm3 in size. Ablation in perivascular
central sites resulted in zones of comparable size and
shape to peripheral sites, averaging 3.8 cm5.3 cm
(volume 44.8 cm3). When inflow occlusion was ap-
plied to central ablation sites, lesion size averaged
4.5 cm6.6 cm (volume 68.9 cm3), not statistically
different. Differences in the shape of ablation zones
were difficult to quantify. In all cases, regardless of
proximity to major vascular structures and application
of inflow occlusion, no evident differences were
observed in the subjective appearance of the shape,
nor the relationship between short-axis and long-axis
diameters. Specifically, parenchymal viability did not
appear to be preserved immediately adjacent to major
Figure 1. Gross section of 100 W, 4 min ablation from freshly
harvested pig liver. Microwave ablation applicator probe is shown
in situ for reference (each line on the probe represents 1 cm). A large
portal venous branch is shown near the probe tip (black arrow). No
heat sink effect is apparent. Histology from the transition zone
(white box) is shown in Figure 2.









2 3.790.6 4.590.9 33.5917.3
4 3.890.5 4.990.5 37.5912.8
8 5.390.6* 6.491.1 92.096.5*
In these studies, all ablations were performed at 100 W in peripheral
locations without inflow occlusion. Lesion lengths and volumes are








Figure 2. Histology of transition zone at margin of ablated lesion
(inset from Figure 1). At the top of the image is necrotic tissue;
normal hepatic parenchyma is at the bottom. The transition zone
in the center of the image reveals infiltration of erythrocytes,
leukocytes, and disruption of the normal hepatic architecture.
H&E, 20.












Peripheral No 3.890.5 4.990.5 37.5912.8
Peripheral Yes 4.490.9 6.190.1* 64.5924.2
Central No 3.891.2 5.390.8 44.8926.3
Central Yes 4.590.1 6.690.3 68.992.8
All ablations were performed at 100 W for 4 min each. Lesion
lengths and volumes are given as mean9one standard deviation.
Volume is calculated as 4/3p(short axis)2(long axis). n3 for each
experiment.
*pB0.05.
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vascular structures and no shape alteration was
observed near these structures.
Post-ablation CT of microwave lesions
CT appearance of regions of microwave ablation
revealed areas of hypodensity and lack of perfusion
(Figure 3). This appearance is similar to that seen
with other methods of thermal ablation. Imaging of
ablation regions at day 7 correlated with the initial
ablation shape and volume of 4 min at 100 W found in
our earlier studies. Serial CT imaging at day 14 and
28 revealed a consistent volume contraction over time
(Figures 3 and 4, Table III). In seven of eight cases,
the lesion volume on day 28 was 2550% of that on
day 7. In one case, the post-ablation site appeared
larger on day 14, decreasing by day 28 to only 77% of
the initial size. A Hounsfield unit analysis of this
lesion suggested that this size increase was likely due
to a bleed around this lesion.
Following the final CT imaging, the ablation sites
were analyzed grossly for size and shape. Lesion
sizes and volumes as measured by CT imaging and
as measured by direct measurement of gross speci-
mens were nearly identical (Table III, columns three
and four). As seen in the initial studies, CT assess-
ment and day 28 gross evaluation of the ablation
sites did not appear to be affected by a heat-sink
effect. Symmetric ellipsoid lesions were seen even in
close proximity to hepatic vasculature. Vessels remain
patent as evidenced by contrast enhancement.
Discussion
These data demonstrate that microwave ablation
utilizing a single application of this high energy single
probe device can result in reproducible and predict-
able large volume lesions in living liver tissue in little
time. Lesion size can be increased by application
of energy for longer duration, particularly beyond
4 min. A single 100 W probe application for 8 min
resulted in lesions consistently 5 cm. This would
typically represent the upper limit for most commer-
cially available RF devices using considerably longer
application times [18].
Based on these results, it appears that thermal
ablation using this microwave device is unaffected
by high blood flow in proximity its application.
Specifically, ablation regions appeared to be of con-
sistent size and symmetric shape, independent of
the location near vascular structures. If validated in
clinical studies, this feature may prove to be particu-
larly advantageous over other ablation methods such
as RFA. Several mechanisms have been postulated
as to why microwave ablation devices resist heat-
sink effects [19]. Unlike RFA, which relies largely on
conductive dissipation of heat, microwave energy is
delivered to a greater distance from the source, relying
less on conductive heat transmission.
The gradual reduction in ablated lesion size over
time was also notable. Lesions consistently underwent
concentric contraction over the 4 week period of this
study. Histologic analysis reveals that the necrotic
liver tissue is gradually replaced by regenerative
hepatic parenchyma. This is not unique to microwave
ablation and has been well described in the literature
with most other ablative techniques including RF,
cryoablation, and HIFU (high intensity focused
ultrasound) [20].
CT was a useful modality for monitoring change in
lesion size/shape over time. On average, CT measure-
ments differed from gross lesion measurement by only
DAY 7 DAY 14 DAY 28
Figure 3. CT imaging demonstrating contraction of lesion over time. The same lesion (white arrows) in a single pig imaged on


















Figure 4. Survival study CT data showing changes in lesion volume
over time. Average volume of ablated lesions on postoperative days
7, 14, and 28 based on CT imaging calculations. Horizontal lines
indicate the averages (n8) for each postoperative day with value
labeled next to each line.
360 M.M. Awad et al.
4 mm. Nevertheless, this level of accuracy may be
insufficient for clinical purposes given that some
neoplastic lesions that are the targets of ablative
therapies are only 1 cm in size. MRI has often been
used in the immediate and postoperative monitoring
of hepatic ablation techniques and may prove
beneficial in monitoring post-microwave ablative
therapies [21].
Compared with RFA, microwave ablation has a
wider zone of active heating. In some reports this can
be up to 6 cm surrounding the antenna [15,2224].
This may allow more uniform tumor killing both
within a targeted area and next to vasculature. Unlike
RF energy, microwave energy does not appear to be
limited by charring and tissue desiccation [14]. In
addition, the time of ablation may be faster, multiple
simultaneous probes can be used, and no return
electrodes are necessary that can lead to inadvertent
skin burns [14,2527]. Finally, the size and shape of
the zone of ablation may be more consistent and less
dependent on heat sinks from vascular structures in
proximity [25,28,29].
Several limitations are notable in this study. First,
while the length of ablation time was varied in these
experiments, a constant ablation power (100 W) was
used. More recent microwave devices in development
can deliver power of 150 W or greater. Other power
settings may result in different ablation characteris-
tics. Second, non-tumor-bearing tissue was used
in these studies. Further studies will help to better
elucidate the effects of this new microwave ablation
probe and its safety in preclinical and clinical settings.
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